Skip to main content
Erschienen in: Acta Neuropathologica 2/2005

01.08.2005 | Regular Paper

Delayed or late-onset type II glycogenosis with globular inclusions

verfasst von: Mehar C. Sharma, Christoph Schultze, Arpad von Moers, Gisela Stoltenburg-Didinger, Yoon S. Shin, Teodor Podskarbi, Klaus Isenhardt, Dominique S. Tews, Hans H. Goebel

Erschienen in: Acta Neuropathologica | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

Three unrelated patients, one girl, one boy, and an adult female, aged 14, 11 and 41 years, respectively, at the time of biopsy, revealed lysosomal glycogen storage, autophagic vacuoles and peculiar globular inclusions of distinct ultrastructure, which were reducing but did not appear like true “reducing bodies” as described in the congenital myopathy “reducing body myopathy”. All three patients had residual activity of acid α-glucosidase in their muscle biopsy samples. Leukocytes in the girl showed normal acid α-glucosidase activity, but in the boy activity was reduced. Molecular genetic analysis of the GAA gene revealed disease-causing mutations in each patient: H568L/R672W, IVS1–13T>G/G615F, and IVS1–13T>G/IVS1–13T>G. Although only one patient with such globular inclusions has been reported up to now, the three patients described here indicate that in the late-onset type of GSD II such inclusions may not be rare.
Literatur
1.
Zurück zum Zitat Angelini C, Cenacchi G, Nascimbeni AC, Fulizio L (2003) Morphological changes in late onset acid maltase deficiency patients with splicing gene mutation. Acta Myol 22:90−96PubMed Angelini C, Cenacchi G, Nascimbeni AC, Fulizio L (2003) Morphological changes in late onset acid maltase deficiency patients with splicing gene mutation. Acta Myol 22:90−96PubMed
2.
Zurück zum Zitat Bertini E, Salviati G, Apollo F, Ricci E, Servidei S, Broccolini A, Papacci M, Tonali P (1994) Reducing body myopathy and desmin storage in skeletal muscle: morphological and biochemical findings. Acta Neuropathol 87:106−112PubMed Bertini E, Salviati G, Apollo F, Ricci E, Servidei S, Broccolini A, Papacci M, Tonali P (1994) Reducing body myopathy and desmin storage in skeletal muscle: morphological and biochemical findings. Acta Neuropathol 87:106−112PubMed
3.
Zurück zum Zitat Boerkoel CF, Exelbert R, Nicastri C, Nichols RC, Miller FW, Plotz PH, Raben N (1995) Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56:887−897PubMed Boerkoel CF, Exelbert R, Nicastri C, Nichols RC, Miller FW, Plotz PH, Raben N (1995) Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56:887−897PubMed
4.
Zurück zum Zitat Brooke MH, Neville HE (1972) Reducing body myopathy. Neurology 22:829−840PubMed Brooke MH, Neville HE (1972) Reducing body myopathy. Neurology 22:829−840PubMed
5.
Zurück zum Zitat Fernandez-Hojas R, Huie ML, Navarro C, Dominguez C, Roig M, Lopez-Coronas D, Teijeira S, Anyane-Yeboa K, Hirschhorn R (2002) Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease). Neuromuscul Disord 12:159−166CrossRefPubMed Fernandez-Hojas R, Huie ML, Navarro C, Dominguez C, Roig M, Lopez-Coronas D, Teijeira S, Anyane-Yeboa K, Hirschhorn R (2002) Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease). Neuromuscul Disord 12:159−166CrossRefPubMed
6.
Zurück zum Zitat Goebel HH, Borchert A (2002) Protein surplus myopathies and other rare congenital myopathies. Semin Pediatr Neurol 9:160−170PubMed Goebel HH, Borchert A (2002) Protein surplus myopathies and other rare congenital myopathies. Semin Pediatr Neurol 9:160−170PubMed
7.
Zurück zum Zitat Goebel HH, Shin YS, Gullotta F, Yokota T, Alroy J, Voit T, Haller P, Schulz A (1992) Adult polyglucosan body myopathy. J Neuropathol Exp Neurol 51:24−35PubMed Goebel HH, Shin YS, Gullotta F, Yokota T, Alroy J, Voit T, Haller P, Schulz A (1992) Adult polyglucosan body myopathy. J Neuropathol Exp Neurol 51:24−35PubMed
8.
Zurück zum Zitat Goebel HH, Halbig LE, Goldfarb L, Schober R, Albani M, Neuen-Jacob E, Voit T (2001) Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: a mixed congenital myopathy. Neuropediatrics 32:196−205CrossRefPubMed Goebel HH, Halbig LE, Goldfarb L, Schober R, Albani M, Neuen-Jacob E, Voit T (2001) Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: a mixed congenital myopathy. Neuropediatrics 32:196−205CrossRefPubMed
9.
Zurück zum Zitat Hagemans MLC, Winkel LPF, Van Doorn PA, Hop WH, Loonen MCB, Reuser AJJ, Van der Ploeg AT (2005) Clinical manifestation and natural course of late-onset Pompe’s disease in 54 Dutch patients. Brain 128:671−677CrossRefPubMed Hagemans MLC, Winkel LPF, Van Doorn PA, Hop WH, Loonen MCB, Reuser AJJ, Van der Ploeg AT (2005) Clinical manifestation and natural course of late-onset Pompe’s disease in 54 Dutch patients. Brain 128:671−677CrossRefPubMed
10.
Zurück zum Zitat Hermans MM, Leenen D van, Kroos MA, Beesley CE, Van Der Ploeg AT, Sakurba H, Wevers R, Kleijer W, Michelakakis H, Kirk EP, et al (2004) Twenty-two novel mutations in lysosomal α-glucosidase gene (GAA) underscores the genotype-phenotype correlation in glycogen storage disease type II. Hum Mutat 23:47−56CrossRefPubMed Hermans MM, Leenen D van, Kroos MA, Beesley CE, Van Der Ploeg AT, Sakurba H, Wevers R, Kleijer W, Michelakakis H, Kirk EP, et al (2004) Twenty-two novel mutations in lysosomal α-glucosidase gene (GAA) underscores the genotype-phenotype correlation in glycogen storage disease type II. Hum Mutat 23:47−56CrossRefPubMed
11.
Zurück zum Zitat Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3389−3420 Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3389−3420
12.
Zurück zum Zitat Hübner G, Pongratz D (1982) Granularkörpermyopathie (sog. reducing body myopathy). Pathologe 3:111−113PubMed Hübner G, Pongratz D (1982) Granularkörpermyopathie (sog. reducing body myopathy). Pathologe 3:111−113PubMed
13.
Zurück zum Zitat Huie ML, Chen AS, Tsujino S, Shanake S, DiMauro S, Engel AG, Hirschhorn R (1994) Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1(-13T>G) mutation in a majority of patients and a novel IVS10(+1GT>CT) mutation. Hum Mol Genet 3:2231−2236PubMed Huie ML, Chen AS, Tsujino S, Shanake S, DiMauro S, Engel AG, Hirschhorn R (1994) Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1(-13T>G) mutation in a majority of patients and a novel IVS10(+1GT>CT) mutation. Hum Mol Genet 3:2231−2236PubMed
14.
Zurück zum Zitat Iancu TC, Lerner A, Shiloh H, Bashan N, Moses S (1988) Juvenile acid maltase deficiency presenting as paravertebral pseudotumour. Eur J Pediatr 147:372−376CrossRefPubMed Iancu TC, Lerner A, Shiloh H, Bashan N, Moses S (1988) Juvenile acid maltase deficiency presenting as paravertebral pseudotumour. Eur J Pediatr 147:372−376CrossRefPubMed
15.
Zurück zum Zitat Jay V, Christodoulou J, Mercer-Connolly A, McInnes RR (1992) “Reducing body”-like inclusions in skeletal muscle in childhood-onset acid maltase deficiency. Acta Neuropathol 85:111−115CrossRefPubMed Jay V, Christodoulou J, Mercer-Connolly A, McInnes RR (1992) “Reducing body”-like inclusions in skeletal muscle in childhood-onset acid maltase deficiency. Acta Neuropathol 85:111−115CrossRefPubMed
16.
Zurück zum Zitat Kiyomoto BH, Murakami N, Kishibayashi J, Sunohara N, Nonaka I (1995) Reducing bodies in distal myopathy with rimmed vacuole formation. Acta Neuropathol 89:109−111CrossRefPubMed Kiyomoto BH, Murakami N, Kishibayashi J, Sunohara N, Nonaka I (1995) Reducing bodies in distal myopathy with rimmed vacuole formation. Acta Neuropathol 89:109−111CrossRefPubMed
17.
Zurück zum Zitat Kiyomoto BH, Murakami N, Kobayashi Y, Nihei K, Tanaka T, Takeshita K, Nonaka I (1995) Fatal reducing body myopathy: ultrastructural and immunohistochemical observations. J Neurol Sci 128:58−65CrossRefPubMed Kiyomoto BH, Murakami N, Kobayashi Y, Nihei K, Tanaka T, Takeshita K, Nonaka I (1995) Fatal reducing body myopathy: ultrastructural and immunohistochemical observations. J Neurol Sci 128:58−65CrossRefPubMed
18.
Zurück zum Zitat Kroos MA, Van der Kraan M, Van den Boogaard MJ, Ausems MGEM, Ploos van Amstel HK, Poenaru L, Nicolino M, Wevers RA, Diggelen OP van, Kleijer WJ, Reuser AJJ (1995) Glycogen storage disease type II: the frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 32:836−837 Kroos MA, Van der Kraan M, Van den Boogaard MJ, Ausems MGEM, Ploos van Amstel HK, Poenaru L, Nicolino M, Wevers RA, Diggelen OP van, Kleijer WJ, Reuser AJJ (1995) Glycogen storage disease type II: the frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 32:836−837
19.
Zurück zum Zitat Lafôret P, Nicolino M, Eymard B, Puech JP, Caillaud C, Poenaru L, Fardeau M (2000) Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology 55:1122−1128PubMed Lafôret P, Nicolino M, Eymard B, Puech JP, Caillaud C, Poenaru L, Fardeau M (2000) Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology 55:1122−1128PubMed
20.
Zurück zum Zitat Minato S, Kobayashi T, Tanaka K, Kitaguchi T, Goto I (1988) Adult Pompe disease with normal acid α-glucosidase activity in leukocytes (in Japanese). Rinsho Shinkeigaku 28:413−416PubMed Minato S, Kobayashi T, Tanaka K, Kitaguchi T, Goto I (1988) Adult Pompe disease with normal acid α-glucosidase activity in leukocytes (in Japanese). Rinsho Shinkeigaku 28:413−416PubMed
21.
Zurück zum Zitat Neudecker S, Krasnianski M, Bahn E, Zierz S (2004) Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature. Acta Neuropathol 108:257−259CrossRefPubMed Neudecker S, Krasnianski M, Bahn E, Zierz S (2004) Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature. Acta Neuropathol 108:257−259CrossRefPubMed
22.
Zurück zum Zitat Radojevic V, Humm AM, Rösler KM, Lauterburg T, Burgunder J-M (2003) Abnormal trafficking of sarcolemmal proteins in α-glucosidase deficiency. Acta Neuropathol 105:373−380PubMed Radojevic V, Humm AM, Rösler KM, Lauterburg T, Burgunder J-M (2003) Abnormal trafficking of sarcolemmal proteins in α-glucosidase deficiency. Acta Neuropathol 105:373−380PubMed
23.
Zurück zum Zitat Shin YS (1990) Diagnosis of glycogen storage disease. J Inherit Metab Dis 13:419−434PubMed Shin YS (1990) Diagnosis of glycogen storage disease. J Inherit Metab Dis 13:419−434PubMed
24.
Zurück zum Zitat Thiéry JP (1967) Mise en evidence des polysaccharides sur coupes fines en microscopie electronique. J Microsc 6:987−1018 Thiéry JP (1967) Mise en evidence des polysaccharides sur coupes fines en microscopie electronique. J Microsc 6:987−1018
Metadaten
Titel
Delayed or late-onset type II glycogenosis with globular inclusions
verfasst von
Mehar C. Sharma
Christoph Schultze
Arpad von Moers
Gisela Stoltenburg-Didinger
Yoon S. Shin
Teodor Podskarbi
Klaus Isenhardt
Dominique S. Tews
Hans H. Goebel
Publikationsdatum
01.08.2005
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 2/2005
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-005-1026-4

Weitere Artikel der Ausgabe 2/2005

Acta Neuropathologica 2/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.